The trademark application PROGNOSTXHEALTH was filed by PrognostX Health Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 13, 2023, and it was registered by office on October 20, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
A transfer of the trademark registration was recorded on June 17, 2024.
Goods And Services
The mark was filed in class 10 with following description of goods:
Diagnostic kits and instruments for diseases and medical use
Testing apparatus and instruments for medical purposes including reagents used to create assays to capture and detect disease biomarkers
Clinical diagnostic and therapeutic apparatuses including computers, software and algorithms for determining medical risk-scores for prediabetes, diabetes, kidney disease, cardiovascular disease, hypertension, eye disease, dementia and solid organ cancers including cancers of the gastrointestinal tract, kidney, lung, liver, pancreas, and bladder.
The mark was filed in class 42 with following description of goods:
Biomedical research services
Scientific laboratory services
Laboratory developed testing
Clinical trial design, statistical evaluation, and execution.
The mark was filed in class 44 with following description of goods:
Diagnostic services relating to diseases
Medical testing services relating to the diagnosis and treatment of disease
Providing reagent sample testing for others in the fields of diseases and medicine
Clinical diagnostic and therapeutic services using computers, software and algorithms for determining medical risk-scores for prediabetes, diabetes, kidney disease, cardiovascular disease, hypertension, eye disease, dementia and solid organ cancers, cancers of the gastrointestinal tract, kidney, lung, liver, pancreas, and bladder
Evaluating clinical utility and applicability of innovative technologies
Medical consulting services related to laboratory developed testing procedures, strategy and execution.